Other Species / Isoforms
  CD22 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
N82-ng
FTGTVLYnATKTEKD
0 1
CD22 (human) FDGTRLYESTKDGKV E78
CD22 iso2 (human) FDGTRLYESTKDGKV E78
CD22 (mouse) FTGTVLYnATKTEKD N82-ng
N111-ng
FLGNRIDnCTLKIHP
0 1
CD22 (human) FLGDKNKNCTLSIHP N101
CD22 iso2 (human) FLGDKNKNCTLSIHP N101
CD22 (mouse) FLGNRIDnCTLKIHP N111-ng
N122-ng
KIHPIRAnDSGNLGL
0 1
CD22 (human) SIHPVHLNDSGQLGL N112
CD22 iso2 (human) SIHPVHLNDSGQLGL N112
CD22 (mouse) KIHPIRAnDSGNLGL N122-ng
N271-ng
NPTEVEKnNSVTMTC
0 1
CD22 (human) SDAIVREGDSVTMTC G258
CD22 iso2 (human) gap -
CD22 (mouse) NPTEVEKnNSVTMTC N271-ng
E309
EDQELEQEQQMSKLI
0 1
CD22 (human) KDGTSLKkQNTFTLN K288-sm
CD22 iso2 (human) gap -
CD22 (mouse) EDQELEQEQQMSKLI E309
N414-ng
VSPWHAGnYSCLAEN
0 1
CD22 (human) ILPWHAGTYSCVAEN T393
CD22 iso2 (human) gap -
CD22 (mouse) VSPWHAGnYSCLAEN N414-ng
N466-ng
VTLVCRYnSSNPDVT
0 1
CD22 (human) VTLSCNYNSSNPSVT N445
CD22 iso2 (human) VTLSCNYNSSNPSVT N268
CD22 (mouse) VTLVCRYnSSNPDVT N466-ng
Y612
AWNLQVLYAPRRLRV
0 1
CD22 (human) AWTLEVLyAPRRLRV Y591-p
CD22 iso2 (human) AWTLEVLYAPRRLRV Y414
CD22 (mouse) AWNLQVLYAPRRLRV Y612
T675-p
EPLEVQHtGsyRCKG
0 1
CD22 (human) EPVKVQHSGAYWCQG S654
CD22 iso2 (human) EPVKVQHSGAYWCQG S477
CD22 (mouse) EPLEVQHtGsyRCKG T675-p
S677-p
LEVQHtGsyRCKGTN
0 1
CD22 (human) VKVQHSGAYWCQGTN A656
CD22 iso2 (human) VKVQHSGAYWCQGTN A479
CD22 (mouse) LEVQHtGsyRCKGTN S677-p
Y678-p
EVQHtGsyRCKGTNG
0 1
CD22 (human) KVQHSGAYWCQGTNS Y657
CD22 iso2 (human) KVQHSGAYWCQGTNS Y480
CD22 (mouse) EVQHtGsyRCKGTNG Y678-p
N736
IQKKWKQNRSQQGLQ
0 1
CD22 (human) LQRRWKRtQsQQGLQ T715-p
CD22 iso2 (human) LQRRWKRTQSQQGLQ T538
CD22 (mouse) IQKKWKQNRSQQGLQ N736
S738
KKWKQNRSQQGLQEN
0 2
CD22 (human) RRWKRtQsQQGLQEN S717-p
CD22 iso2 (human) RRWKRTQSQQGLQEN S540
CD22 (mouse) KKWKQNRSQQGLQEN S738
S746-p
QQGLQENssGQsFFV
0 1
CD22 (human) QQGLQENSSGQSFFV S725
CD22 iso2 (human) QQGLQENSSGQSFFV S548
CD22 (mouse) QQGLQENssGQsFFV S746-p
S747-p
QGLQENssGQsFFVR
0 2
CD22 (human) QGLQENSSGQSFFVR S726
CD22 iso2 (human) QGLQENSSGQSFFVR S549
CD22 (mouse) QGLQENssGQsFFVR S747-p
S750-p
QENssGQsFFVRNKK
0 2
CD22 (human) QENSSGQSFFVRNKK S729
CD22 iso2 (human) QENSSGQSFFVRNKK S552
CD22 (mouse) QENssGQsFFVRNKK S750-p
Y773-p
GPQSQGCyNPAMDDT
1 0
CD22 (human) GPHSLGCYNPMMEDG Y752
CD22 iso2 (human) GPHSLGCYNPMMEDG Y575
CD22 (mouse) GPQSQGCyNPAMDDT Y773-p
Y783-p
AMDDTVSyAILRFPE
Upstream
Downstream
5 1
Effects on Modified Protein
  • activity, inhibited
  • molecular association, regulation
  • phosphorylation
Treatment
  • antibody
  • piceatannol
  • PP2
CD22 (human) MMEDGISyTTLRFPE Y762-p
CD22 iso2 (human) MMEDGISYTTLRFPE Y585
CD22 (mouse) AMDDTVSyAILRFPE Y783-p
Y817-p
NNSDSVTySVIQKRP
Downstream
3 7
Effects on Modified Protein
  • molecular association, regulation
  • phosphorylation
CD22 (human) DCDDTVTySALHkRQ Y796-p
CD22 iso2 (human) DCDDTVTYSALHKRQ Y619
CD22 (mouse) NNSDSVTySVIQKRP Y817-p
K822
VTySVIQKRPMGDyE
0 1
CD22 (human) VTySALHkRQVGDyE K801-ub
CD22 iso2 (human) VTYSALHKRQVGDYE K624
CD22 (mouse) VTySVIQKRPMGDyE K822
Y828-p
QKRPMGDyENVNPSC
Upstream
Downstream
6 1
Effects on Modified Protein
  • activity, inhibited
  • molecular association, regulation
Treatment
  • antibody
  • piceatannol
  • PP2
CD22 (human) HkRQVGDyENVIPDF Y807-p
CD22 iso2 (human) HKRQVGDYENVIPDF Y630
CD22 (mouse) QKRPMGDyENVNPSC Y828-p
Y843-p
PEDESIHysELVQFG
Upstream
Downstream
6 5
Effects on Modified Protein
  • activity, inhibited
  • molecular association, regulation
  • phosphorylation
Treatment
  • antibody
  • antigenic stimulation
  • latrunculin_A
  • piceatannol
  • PP2
CD22 (human) PEDEGIHySELIQFG Y822-p
CD22 iso2 (human) PEDEGIHYSELIQFG Y645
CD22 (mouse) PEDESIHysELVQFG Y843-p
S844-p
EDESIHysELVQFGA
0 2
CD22 (human) EDEGIHySELIQFGV S823
CD22 iso2 (human) EDEGIHYSELIQFGV S646
CD22 (mouse) EDESIHysELVQFGA S844-p
Y863-p
QAKEDVDyVTLKH__
Upstream
Downstream
6 12
Effects on Modified Protein
  • activity, inhibited
  • molecular association, regulation
  • phosphorylation
Treatment
  • antibody
  • antigenic stimulation
  • piceatannol
  • PP2
CD22 (human) QAQENVDyVILKH__ Y842-p
CD22 iso2 (human) QAQENVDYVILKH__ Y665
CD22 (mouse) QAKEDVDyVTLKH__ Y863-p